Ortin Laboratories (Small Cap) Share Target 2024, 2025 To 2039
|
Ortin Laboratories Limited |
|||
|
Price: ₹18.04 | ||
| 52 Week Low: ₹16.20 52 Week High: ₹25.00 |
|||
| Market Capital: 16.56 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Ortin Laboratories Share Price Target For 2024
- 1.1.1: Ortin Laboratories Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Ortin Laboratories Share Price Target For 2025
- 1.2.1: Ortin Laboratories Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Ortin Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Ortin Laboratories Brief Company Overview
- 4: Ortin Laboratories Financial Performance
- 4.0.1: Is Ortin Laboratories A Good Buy For Long Term?
To predict the Ortin Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Ortin Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Ortin Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ortin Laboratories shares in 2024, see the table below.
Ortin Laboratories Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 18.79 (+4.15%) | Price Action: 23 Oct 2024 High |
| 2024 Target 2 | 18.6 (+3.1%) | Price Action: 20 Nov 2023 Low |
| 2024 Target 1 | 18.4 (+1.99%) | Price Action: Aug 2008 High |
| Current Price | 18.04 | Ortin Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 17.84 (-1.11%) | Fibonacci Retracement Level 98.60% |
| Stop Loss 2 | 17.65 (-2.17%) | Price Action: Oct 2007 High |
| Stop Loss 3 | 17.45 (-3.28%) | Price Action: 06 Nov 2023 Low |
Short-Term Technical Outlook
Current Technical Position: Ortin Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹18.99 serves as the nearest technical reference point.
Historical Returns: 3-month: -15.15% | 6-month: -6.82% | 1-year: -21.9%
Ortin Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Ortin Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ortin Laboratories shares in 2025, see the table below.
Ortin Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 25.0 (+38.58%) | Price Action: 26 Dec 2023 High |
| 2025 Target 2 | 24.7 (+36.9%) | Price Action: 22 Dec 2023 Low |
| 2025 Target 1 | 24.45 (+35.53%) | Price Action: 27 Dec 2023 High |
| Current Price | 18.04 | Ortin Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 16.5 (-8.53%) | Price Action: May 2024 Low |
| Stop Loss 2 | 16.3 (-9.65%) | Price Action: May 2010 Low |
| Stop Loss 3 | 16.1 (-10.76%) | Price Action: Jan 2008 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Ortin Laboratories is currently trading near its 52-week low of ₹16.2, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -21.9% | 3-year: -45.83% | 5-year: -12.51%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Ortin Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹18.04 | ||
| 2024 | ₹18.51 | +2.6% | ₹18.84 |
| 2025 | ₹20.46 | +10.53% | ₹21.09 |
| 2026 | ₹21.21 | +3.66% | ₹21.53 |
| 2027 | ₹21.23 | +0.09% | ₹21.55 |
| 2028 | ₹19.51 | -8.1% | ₹21.56 |
| 2029 | ₹19.33 | -0.92% | ₹21.79 |
| 2030 | ₹21.35 | +10.45% | ₹22.02 |
| 2031 | ₹22.13 | +3.65% | ₹22.46 |
| 2032 | ₹22.15 | +0.09% | ₹22.48 |
| 2033 | ₹20.34 | -8.17% | ₹22.48 |
| 2034 | ₹20.15 | -0.93% | ₹22.71 |
| 2035 | ₹22.25 | +10.42% | ₹22.94 |
| 2036 | ₹23.05 | +3.59% | ₹23.40 |
| 2037 | ₹23.06 | +0.04% | ₹23.41 |
| 2038 | ₹21.17 | -8.19% | ₹23.41 |
| 2039 | ₹21.34 | +0.8% | ₹23.64 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Ortin Laboratories Brief Company Overview
Ortin Laboratories: A Leading Pharma PowerhouseEstablished in 1986, Ortin Laboratories has emerged as a prominent player in India's pharmaceutical industry. Headquartered in Hyderabad, the company engages in manufacturing and trading a diverse range of pharmaceuticals, drugs,...
and intermediates.Known for its commitment to quality and innovation, Ortin Laboratories has garnered a solid reputation in the industry. Their products and services cater to a wide range of healthcare needs, including anti-diabetics, anti-allergics, antibiotics, and cardiovascular medications.Ortin Laboratories' extensive product portfolio encompasses various formulations such as tablets, capsules, syrups, and powders. They also offer active pharmaceutical ingredients (APIs), fine chemicals, and grignard and alkali metal products.Beyond manufacturing, Ortin Laboratories provides specialized services in process development, analytical research, assay development, and diagnostics. They also undertake long-term contracts for manufacturing intermediates and developing new APIs, demonstrating their commitment to innovation and growth.Ortin Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 16.56 Crore | Market valuation of Ortin Laboratories's shares. |
| Revenue (TTM) | 74.92 Lakh | Total revenue generated by Ortin Laboratories over the past twelve months. |
| Net Income (TTM) | -8.16 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -49.76% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +43.69% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-86.7% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
63.82 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.8 Crore | Sum of Ortin Laboratories's current & long-term financial obligations. |
| Total Cash | 2.34 Crore | Total amount of liquid funds available to Ortin Laboratories. |
| Beta | 1.36 | Beta is greater than 1 indicating that the Ortin Laboratories's price is more volatile than the market. |
Is Ortin Laboratories A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
